ACTELION LTD Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (6)

Latest Posts

About This Stock More About This Stock
Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug
Article By: Arpita Dutt
Wednesday, December 21, 2016 10:55 AM EST
Conatus is ending the year on a high note with the company signing a lucrative deal with Swiss pharma giant, Novartis. Investors applauded the deal sending the company’s shares soaring 141.3%.
In this article: ALIOF, ALXN, BIIB, CLVS, GILD, CNAT, TSRO
Read
Actelion Remains In M&A Spotlight, ASH Data In Focus
Article By: Arpita Dutt
Wednesday, December 7, 2016 6:01 PM EST
Switzerland-based Actelion continued to be a part of acquisition chatter with Sanofi now rumored to be interested in the company.
In this article: ALIOF, AMGN, CELG, VRTX, ABBV, AGIO, KITE
Read
Lilly Alzheimer's Drug Fails, J&J In Acquisition Talks With ALIOF
Article By: Arpita Dutt
Monday, November 28, 2016 11:59 AM EST
Does Johnson & Johnson’s interest in acquiring Actelion imply the beginning of increased merger and acquisition (M&A) activity in the pharma and biotech sector?
In this article: AGN, AZN, BMY, JNJ, LLY, MRK, ALIOF
Read
Lung Disease Stocks Advance After Actelion Approached By J&J
Article By: The Fly
Friday, November 25, 2016 5:04 PM EST
Actelion, a Switzerland-based biopharmaceutical company, and drug giant Johnson & Johnson confirmed they were in preliminary discussions regarding a potential transaction.
In this article: ALIOF, JNJ Also: SNY, NVS, AHPI, INSM, PRQR, UTHR
Read
Four Best Biotech Stocks Of The First Quarter Of 2016
Article By: Zacks Investment Research
Sunday, April 3, 2016 7:19 AM EST
The entry of the first FDA-approved biosimilar, Zarxio, a biosimilar version of Amgen’s blockbuster drug, Neupogent, last year has left biotech companies vying to enter this high revenue generating space. Biosimilars are the next big thing.
In this article: KIN, CRMD, ALIOF, MESO Also: AMGN, GILD, SHPG, BXLT
Read

PARTNER HEADLINES

Latest Tweets for $ALIOF

No tweets yet!